Skip to main content
SpringerLink
Log in

Surexpression de l’oncoprotéine HER2 en pathologie mammaire dans une population de l’ouest algérien

  • Conference paper
Cancer du sein : surdiagnostic, surtraitement

  • 148 Accesses

Résumé

Dans l’ouest algérien, la fréquence du cancer du sein a augmenté de 19,5 % de 1996 à 2004. Avec une incidence standardisée de 36,9/100 000. Le carcinome canalaire invasif est le type histologique le plus retrouvé.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Références

  1. Baselga J, Norton L, Albanell J et al. (1998) Recombinant humanized anti-HER2 antibody (herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2: neu overexpressing human breast cancer xenografts. Cancer Res 58: 2825–2831

    PubMed  CAS  Google Scholar 

  2. Couturier J, Vincent-Salomon A, Zafrani B, Sastre-Garau X (2000) Strong correlation between results of fluorescent in situ hybridization and immunohistochemisstry for the assessment of ERBB2(HER-2/ neu) gene status 2 or p53 expression regardingin breast carcinoma. Mod Pathol 13: 1238–1243

    Article  PubMed  CAS  Google Scholar 

  3. Hoang MP, Sahin AA, Ordonez NG, Sneidge N (2000) HER-2/neu gene amplification compared with HER2-2/neu protein overexpression and intraobserver reproducibility in invasive breast carcinoma. Am J Clin Pathol 113: 852–859

    Article  PubMed  CAS  Google Scholar 

  4. Staaf J, Ringner M, Vallon-Christersson J et al. (2010) Identification of subtypes in Human Epidermal Growth Factor 2-positivebreast cancer reeals a gene signature prognostic of out-come. J Clin Oncol 28: 1813–1820

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de biologie du développement et de la différenciation (LBDD), Faculté des Sciences, Université d’ORAN ES-SENIA, Oran, Algérie

    C. Zaoui, Z. Bekkouche & F. Z. Elkebir

  2. Chirurgie générale, clinique chirurgicale A, CHUO, Algérie

    K. Seddiki Brahmi

  3. Laboratoire de cytologie et d’anatomie pathologique, Oran, Algérie

    B. Merad

  4. SEMEP, EHU, Oran, Algérie

    K. Terki

Authors
  1. C. Zaoui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z. Bekkouche
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Seddiki Brahmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Terki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Merad
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Z. Elkebir
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag France, Paris

About this paper

Cite this paper

Zaoui, C., Bekkouche, Z., Seddiki Brahmi, K., Terki, K., Merad, B., Elkebir, F.Z. (2012). Surexpression de l’oncoprotéine HER2 en pathologie mammaire dans une population de l’ouest algérien. In: Cancer du sein : surdiagnostic, surtraitement. Springer, Paris. https://doi.org/10.1007/978-2-8178-0249-7_77

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0249-7_77

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0248-0

  • Online ISBN: 978-2-8178-0249-7

Publish with us

Policies and ethics

Search

Navigation